A citation-based method for searching scientific literature

Lucie Beresova, Eva Vesela, Ivo Chamrad, Jiri Voller, Masayuki Yamada, Tomas Furst, Rene Lenobel, Katarina Chroma, Jan Gursky, Katerina Krizova, Martin Mistrik, Jiri Bartek. J Proteome Res 2016
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
Michael Crump, Tara Baetz, Stephen Couban, Andrew Belch, Deborah Marcellus, Kang Howson-Jan, Kevin Imrie, Robert Myers, Grenfell Adams, Keyue Ding,[...]. Cancer 2004
97
100



A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
T Kühr, S Burgstaller, U Apfelbeck, W Linkesch, H Seewann, M Fridrik, G Michlmayr, O Krieger, D Lutz, W Lin,[...]. Leuk Res 2003
18
100

Antiangiogenic potential of camptothecin and topotecan.
M K Clements, C B Jones, M Cumming, S S Daoud. Cancer Chemother Pharmacol 1999
98
100

Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.
Matilde Murga, Stefano Campaner, Andres J Lopez-Contreras, Luis I Toledo, Rebeca Soria, Maria F Montaña, Luana D' Artista, Thomas Schleker, Carmen Guerra, Elena Garcia,[...]. Nat Struct Mol Biol 2011
251
100

Checkpoint-dependent RNR induction promotes fork restart after replicative stress.
Esther C Morafraile, John F X Diffley, José Antonio Tercero, Mónica Segurado. Sci Rep 2015
12
100

Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding.
M Eriksson, U Uhlin, S Ramaswamy, M Ekberg, K Regnström, B M Sjöberg, H Eklund. Structure 1997
196
100


Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species.
Monika A Papież, Wirginia Krzyściak, Krzysztof Szade, Karolina Bukowska-Straková, Magdalena Kozakowska, Karolina Hajduk, Beata Bystrowska, Jozef Dulak, Alicja Jozkowicz. Drug Des Devel Ther 2016
22
100

Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry.
Zbigniew Darzynkiewicz, H Dorota Halicka, Hong Zhao, Monika Podhorecka. Methods Mol Biol 2011
28
100


Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
S Shamimi-Noori, W-S Yeow, M F Ziauddin, H Xin, T L N Tran, J Xie, A Loehfelm, P Patel, J Yang, D S Schrump,[...]. Cancer Gene Ther 2008
34
100



BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest.
Ronit I Yarden, Sally Metsuyanim, Itay Pickholtz, Shabana Shabbeer, Hadass Tellio, Moshe Z Papa. Int J Biochem Cell Biol 2012
19
100

Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Alexandre Rouette, Sophie Parent, Julie Girouard, Valérie Leblanc, Eric Asselin. Int J Cancer 2012
19
100

Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells.
S Kharbanda, E Rubin, H Gunji, H Hinz, B Giovanella, P Pantazis, D Kufe. Cancer Res 1991
78
100

A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells.
Giang Huong Nguyen, Thomas S Dexheimer, Andrew S Rosenthal, Wai Kit Chu, Dharmendra Kumar Singh, Georgina Mosedale, Csanád Z Bachrati, Lena Schultz, Masaaki Sakurai, Pavel Savitsky,[...]. Chem Biol 2013
94
100

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.
Anna M Azarova, Yi Lisa Lyu, Chao-Po Lin, Yuan-Chin Tsai, Johnson Yiu-Nam Lau, James C Wang, Leroy F Liu. Proc Natl Acad Sci U S A 2007
198
100

24
100


Chromosomal fragile sites.
G R Sutherland. Genet Anal Tech Appl 1991
66
100

RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells.
Ryan L Ragland, Sima Patel, Rebecca S Rivard, Kevin Smith, Ashley A Peters, Anja-Katrin Bielinsky, Eric J Brown. Genes Dev 2013
67
100


DNA damage response and tumorigenesis in Mcm2-deficient mice.
D Kunnev, M E Rusiniak, A Kudla, A Freeland, G K Cady, S C Pruitt. Oncogene 2010
63
100

Role of the p38 MAPK pathway in cisplatin-based therapy.
Javier Hernández Losa, Carlos Parada Cobo, Juan Guinea Viniegra, Victor Javier Sánchez-Arevalo Lobo, Santiago Ramón y Cajal, Ricardo Sánchez-Prieto. Oncogene 2003
136
100



The DNA replication checkpoint response stabilizes stalled replication forks.
M Lopes, C Cotta-Ramusino, A Pellicioli, G Liberi, P Plevani, M Muzi-Falconi, C S Newlon, M Foiani. Nature 2001
597
100

Hydroxyurea-induced cell death as related to cell cycle in mouse and human T-lymphoma cells.
S Skog, B Tribukait, B Wallström, S Eriksson. Cancer Res 1987
20
100

Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide.
Chyuan-Chuan Wu, Tsai-Kun Li, Lynn Farh, Li-Ying Lin, Te-Sheng Lin, Yu-Jen Yu, Tien-Jui Yen, Chia-Wang Chiang, Nei-Li Chan. Science 2011
286
100

Fanconi anemia: a disorder defective in the DNA damage response.
Hiroyuki Kitao, Minoru Takata. Int J Hematol 2011
55
100

MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.
A M Rodriguez-Lopez, D Xenaki, T O Eden, J A Hickman, C M Chresta. Mol Pharmacol 2001
45
100

Checkpoint-mediated control of replisome-fork association and signalling in response to replication pausing.
Chiara Lucca, Fabio Vanoli, Cecilia Cotta-Ramusino, Achille Pellicioli, Giordano Liberi, James Haber, Marco Foiani. Oncogene 2004
128
100


ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress.
Masayuki Yamada, Kenji Watanabe, Martin Mistrik, Eva Vesela, Iva Protivankova, Niels Mailand, MyungHee Lee, Hisao Masai, Jiri Lukas, Jiri Bartek. Genes Dev 2013
52
100

UV stalled replication forks restart by re-priming in human fibroblasts.
Ingegerd Elvers, Fredrik Johansson, Petra Groth, Klaus Erixon, Thomas Helleday. Nucleic Acids Res 2011
92
100

Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.
Mélanie Gressette, Benjamin Vérillaud, Anne-Sophie Jimenez-Pailhès, Hélène Lelièvre, Kwok-Wai Lo, François-Régis Ferrand, Charles-Henry Gattolliat, Anne Jacquet-Bescond, Laurence Kraus-Berthier, Stéphane Depil,[...]. PLoS One 2014
29
100


Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs.
Wolf Wrasidlo, Ulrike Schröder, Kathrin Bernt, Nicole Hübener, Doron Shabat, Gerhard Gaedicke, Holger Lode. Bioorg Med Chem Lett 2002
18
100


Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
Daniel Sypniewski, Ilona Bednarek, Sabina Gałka, Tomasz Loch, Daria Błaszczyk, Dagna Sołtysik. Acta Pol Pharm 2013
5
100


Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Shumei Zhang, Caixia Lu, Xiaoli Zhang, Junsheng Li, Hong Jiang. Drug Deliv 2016
12
100

DNA damage tolerance: when it's OK to make mistakes.
Debbie J Chang, Karlene A Cimprich. Nat Chem Biol 2009
137
100


Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia.
Calum Leitch, Tereza Osdal, Vibeke Andresen, Maren Molland, Silje Kristiansen, Xuan Nhi Nguyen, Øystein Bruserud, Bjørn Tore Gjertsen, Emmet McCormack. Oncotarget 2016
16
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.